Quote | Petros Pharmaceuticals Inc. (NASDAQ:PTPI)
Last: | $0.677 |
---|---|
Change Percent: | -2.74% |
Open: | $0.675 |
Close: | $0.677 |
High: | $0.71 |
Low: | $0.665 |
Volume: | 117,556 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
News | Petros Pharmaceuticals Inc. (NASDAQ:PTPI)
--News Direct-- Petros Pharmaceuticals CEO Fady Boctor joined Steve Darling from Proactive to share exciting developments with Proactive, highlighting a new collaboration with Lemonaid Health, a prominent telemedicine provider and subsidiary of 23andMe. Through this collaboration, Lemonai...
Collaboration with leading telemedicine provider to offer marketing and distribution of STENDRA for Lemonaid Health's ED patients (Please see important safety information below) NEW YORK, NY / ACCESSWIRE / April 23, 2024 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI), a company focused on ...
Message Board Posts | Petros Pharmaceuticals Inc. (NASDAQ:PTPI)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $PTPI TY https://investorshangout.com/images/MYImages/499948275_SmartSelect_20230425_17483 | znewcar1 | investorshangout | 04/26/2023 2:19:29 PM |
znewcar1: $PTPI S@5.05ish yet failed to BO5.75 twice does it make 3? a fail could BD | znewcar1 | investorshangout | 04/25/2023 3:46:51 PM |
PTPL is prescribed for Peyronie's disease or in | subslover | investorshub | 04/25/2023 2:22:05 PM |
$PTPI: And they gots all of that MENS' | Invest-in-America | investorshub | 04/25/2023 2:17:23 PM |
znewcar1: $PTPI Hod6.19 BO4.6 to HOD S5? | znewcar1 | investorshangout | 04/25/2023 2:15:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Petros Pharmaceuticals Inc. Company Name:
PTPI Stock Symbol:
NASDAQ Market:
--News Direct-- Petros Pharmaceuticals CEO Fady Boctor joined Steve Darling from Proactive to share exciting developments with Proactive, highlighting a new collaboration with Lemonaid Health, a prominent telemedicine provider and subsidiary of 23andMe. Through this collaboration, Lemonai...
Collaboration with leading telemedicine provider to offer marketing and distribution of STENDRA for Lemonaid Health's ED patients (Please see important safety information below) NEW YORK, NY / ACCESSWIRE / April 23, 2024 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI), a company focused on ...
(Please see important safety information below) NEW YORK, NY / ACCESSWIRE / April 16, 2024 / Petros Pharmaceuticals, Inc. ("Petros," or the "Company") (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- counter (OTC) drug development programs, announ...